For Pemphigus, Rituximab Is First Line, Expert Says

Lower healthcare costs and efficacy put rituximab ahead of traditional treatments, such as corticosteroids, doxycycline, and immunomodulators, for the autoimmune blistering disease, an expert said.
Medscape Medical News